5 results on '"Angelica Mercandino"'
Search Results
2. Adherence to Dietary Recommendations after One Year of Intervention in Breast Cancer Women: The DIANA-5 Trial
- Author
-
Eleonora Bruno, Maggiorino Barbero, Rosalba Amodio, Emanuela Zagallo, Maria Chiara Bassi, Salvatore Panico, Rocco Galasso, Anna Villarini, Manuela Bellegotti, Milena Simeoni, Maurizio Zarcone, Maria Piera Mano, Sara Grioni, Elisabetta Venturelli, Vittorio Krogh, Giuliana Gargano, Bernardo Bonanni, Patrizia Pasanisi, Franco Berrino, Angelica Mercandino, and Maria Santucci de Magistris
- Subjects
Adult ,medicine.medical_specialty ,Randomization ,Mediterranean diet ,Breast Neoplasms ,DIANA-5 ,Diet, Mediterranean ,Article ,Breast cancer ,adherence to diet ,Intervention (counseling) ,Internal medicine ,Weight Loss ,medicine ,Humans ,TX341-641 ,Aged ,Metabolic Syndrome ,Nutrition and Dietetics ,business.industry ,Nutrition. Foods and food supply ,Incidence (epidemiology) ,Body Weight ,Odds ratio ,Middle Aged ,Anthropometry ,medicine.disease ,Weight Reduction Programs ,weight and metabolic syndrome improvement ,Patient Compliance ,Female ,Metabolic syndrome ,business ,Follow-Up Studies ,Food Science - Abstract
The Diet and Androgen-5 (DIANA-5) trial aimed at testing whether a dietary change based on the Mediterranean diet and on macrobiotic principles can reduce the incidence of breast cancer (BC)-related events. We analyzed the adherence to the DIANA-5 dietary recommendations by randomization group after 1 year of intervention. We evaluated the association between dietary adherence and changes in body weight and metabolic syndrome (MS) parameters. BC women aged 35–70 years were eligible. After the baseline examinations, women were randomized into an intervention group (IG) or a control group (CG). A total of 1344 BC women (689 IG and 655 CG) concluded the first year of dietary intervention. IG showed greater anthropometric and metabolic improvements compared to CG. These changes were significantly associated with increased adherence to the dietary recommendations. Women who increased recommended foods consumption or reduced discouraged foods consumption showed an Odds Ratio (OR) of 1.37 (0.70–2.67) and 2.02 (1.03–3.98) to improve three or more MS parameters. Moreover, women in the higher category of dietary change showed a four times higher OR of reducing body weight compared to the lower category (p <, 0.001). The DIANA-5 dietary intervention is effective in reducing body weight and MS parameters.
- Published
- 2021
3. Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patients
- Author
-
Harriet Johansson, Patrizia Pasanisi, Franco Berrino, Angelica Mercandino, Maria Chiara Bassi, Maggiorino Barbero, Elena Consolaro, Rocco Galasso, Emanuela Zagallo, Eleonora Bruno, Maria Santucci de Magistris, Giuliana Gargano, Anna Villarini, Adele Traina, Milena Simeoni, Maria Piera Mano, Manuela Bellegotti, Maurizio Zarcone, and Elisabetta Venturelli
- Subjects
Cancer Research ,medicine.medical_specialty ,Cancer prevention ,business.industry ,Incidence (epidemiology) ,Cancer ,medicine.disease ,Confidence interval ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Oncology ,030220 oncology & carcinogenesis ,Internal medicine ,medicine ,Physical therapy ,030212 general & internal medicine ,medicine.symptom ,Metabolic syndrome ,Stage (cooking) ,business ,Abdominal obesity - Abstract
Metabolic syndrome (MetS), conventionally defined by the presence of at least three out of five dismetabolic traits (abdominal obesity, hypertension, low plasma HDL-cholesterol and high plasma glucose and triglycerides), has been associated with both breast cancer (BC) incidence and prognosis. We investigated the association between the prevalence of MetS and a score of adherence to the World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) recommendations for the prevention of cancer in a cross-sectional study of BC patients. The DIet and ANdrogen-5 study (DIANA-5) for the prevention of BC recurrences recruited 2092 early stage BC survivors aged 35-70. At recruitment, all women completed a 24-hour food frequency and physical activity diary on their consumption and activity of the previous day. Using these diaries we created a score of adherence to five relevant WCRF/AICR recommendations. The prevalence ratios (PRs) and 95% confidence intervals (CIs) of MetS associated with the number of recommendations met were estimated using a binomial regression model. The adjusted PRs of MetS decreased with increasing number of recommendations met (p < 0.001). Meeting all the five recommendations versus meeting none or only one was significantly associated with a 57% lower MetS prevalence (95% CI 0.35-0.73). Our results suggest that adherence to WCRF/AICR recommendations is a major determinant of MetS and may have a clinical impact.
- Published
- 2015
4. Metabolic syndrome and breast cancer prognosis
- Author
-
Harriet Johansson, Giuliana Gargano, Patrizia Pasanisi, Maggiorino Barbero, Angelica Mercandino, Salvatore Panico, Franco Berrino, Maria Chiara Bassi, Maria Piera Mano, Eleonora Bruno, Elisabetta Venturelli, Adele Traina, Elena Consolaro, Anna Villarini, Milena Simeoni, Maurizio Zarcone, Rocco Galasso, Bernardo Bonanni, Berrino, F, Villarini, A, Traina, A, Bonanni, B, Panico, Salvatore, Mano, Mp, Mercandino, A, Galasso, R, Barbero, M, Simeoni, M, Bassi, Mc, Consolaro, E, Johansson, H, Zarcone, M, Bruno, E, Gargano, G, Venturelli, E, and Pasanisi, P.
- Subjects
Adult ,Oncology ,Cancer Research ,medicine.medical_specialty ,Breast Neoplasms ,Body Mass Index ,Metastasis ,Breast cancer ,Risk Factors ,Internal medicine ,medicine ,Humans ,Breast cancer prognosis ,Survival rate ,Abdominal obesity ,Aged ,Neoplasm Staging ,Physical activity ,business.industry ,Middle Aged ,Prognosis ,medicine.disease ,Metabolic syndrome ,Obesity ,Confidence interval ,Diet ,Surgery ,Survival Rate ,Logistic Models ,Female ,Neoplasm Grading ,medicine.symptom ,business ,Body mass index ,Follow-Up Studies - Abstract
Metabolic syndrome (MS), conventionally defined by the presence of at least three out of five dysmetabolic traits (abdominal obesity, hypertension, low plasma HDL-cholesterol, high plasma glucose and high triglycerides), has been associated with an increased risk of several age-related chronic diseases, including breast cancer (BC). This may have prognostic implications for BC survivors. 2,092 early stage BC survivors aged 35-70, recruited in eleven Italian centres 0-5 years after surgical treatment (1.74 years on average), were followed-up over 2.8 years on average for additional BC-related events, including BC-specific mortality, distant metastasis, local recurrences and contralateral BC. At recruitment, 20 % of the patients had MS. Logistic regression models were carried out to generate OR and 95 % confidence intervals (CI) for new BC events associated with MS, adjusting for baseline pathological prognostic factors. New BC events occurred in 164 patients, including 89 distant metastases. The adjusted ORs for women with MS versus women without any MS traits were 2.17 (CI 1.31-3.60) overall, and 2.45 (CI 1.24-4.82) for distant metastasis. The OR of new BC events for women with only one or two MS traits was 1.40 (CI 0.91-2.16). All MS traits were positively associated with new BC events, and significantly so for low HDL and high triglycerides. MS is an important prognostic factor in BC. As MS is reversible through lifestyle changes, interventions to decrease MS traits in BC patients should be implemented in BC clinics.
- Published
- 2014
5. Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patients
- Author
-
Eleonora, Bruno, Giuliana, Gargano, Anna, Villarini, Adele, Traina, Harriet, Johansson, Maria Piera, Mano, Maria, Santucci De Magistris, Milena, Simeoni, Elena, Consolaro, Angelica, Mercandino, Maggiorino, Barbero, Rocco, Galasso, Maria Chiara, Bassi, Maurizio, Zarcone, Emanuela, Zagallo, Elisabetta, Venturelli, Manuela, Bellegotti, Franco, Berrino, and Patrizia, Pasanisi
- Subjects
Adult ,Metabolic Syndrome ,Cancer Research ,Advance Directive Adherence ,adherence to WCRF/AICR recommendation ,breast cancer prognosis ,metabolic syndrome prevalence ,Aged ,Breast Neoplasms ,Diet ,Feeding Behavior ,Female ,Humans ,Life Style ,Middle Aged ,Motor Activity ,Neoplasm Staging ,Prevalence ,Risk Factors ,Oncology - Abstract
Metabolic syndrome (MetS), conventionally defined by the presence of at least three out of five dismetabolic traits (abdominal obesity, hypertension, low plasma HDL-cholesterol and high plasma glucose and triglycerides), has been associated with both breast cancer (BC) incidence and prognosis. We investigated the association between the prevalence of MetS and a score of adherence to the World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) recommendations for the prevention of cancer in a cross-sectional study of BC patients. The DIet and ANdrogen-5 study (DIANA-5) for the prevention of BC recurrences recruited 2092 early stage BC survivors aged 35-70. At recruitment, all women completed a 24-hour food frequency and physical activity diary on their consumption and activity of the previous day. Using these diaries we created a score of adherence to five relevant WCRF/AICR recommendations. The prevalence ratios (PRs) and 95% confidence intervals (CIs) of MetS associated with the number of recommendations met were estimated using a binomial regression model. The adjusted PRs of MetS decreased with increasing number of recommendations met (p 0.001). Meeting all the five recommendations versus meeting none or only one was significantly associated with a 57% lower MetS prevalence (95% CI 0.35-0.73). Our results suggest that adherence to WCRF/AICR recommendations is a major determinant of MetS and may have a clinical impact.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.